Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 2 Promoter Buying 1 Financial Results 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 Aug 2026 11:17 IST BSE

Promoter Buying

Beryl Drugs Promoter Buying

Sudhir Sethi, a promoter of Beryl Drugs Limited, acquired 3,000 equity shares via market transactions. This acquisition increases the promoter's total stake from 10.08% to 10.14%.

Read the filing ↗